NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Maternal Spindle Transfer May Revolutionize Fertility Treatment – Embryotools S.L.
Embryotools S.L./LinkedIn
May 14, 2026, 10:16

Maternal Spindle Transfer May Revolutionize Fertility Treatment – Embryotools S.L.

Embryotools S.L. shared a post on LinkedIn։

“Great insights from our co-founder, Dr. Nuno Costa Borges, at the recent EBART Congress.

During his presentation, Nuno delved into the clinical adoption path and the latest outcomes of Maternal Spindle Transfer (MST).

MST is no longer just a tool for preventing mitochondrial diseases. Latest results confirm that it could be a breakthrough solution for patients with poor oocyte quality and recurrent IVF failures.

  • Data from pilot trials show blastocyst euploidy and live birth rates that offer new hope to patients who previously had no options using their own oocytes.
  • MST helps ‘rescue’ the developmental potential of oocytes with diminished metabolic activity, as evidenced by recent research using non-invasive hyperspectral imaging.
  • Once again, scientific innovation is advancing faster than regulatory frameworks. The challenge ahead is not only technical but also legal and ethical as we move toward global clinical adoption.

At Embryotools S.L., we remain committed to developing and training in cutting-edge techniques that are shaping the future of assisted reproduction.”

Embryotools S.L.

Stay updated on all scientific advances in the field of fertility with Fertility News.

assisted reproduction EBART Congress Embryotools S.L. Fertility Fertility News IVF IVF failures Maternal Spindle Transfer metabolic activity mitochondrial diseases MST non-invasive hyperspectral imaging Nuno Costa Borges reproductive health Reproductive Medicine
NewsFeed